Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
6.20
-2.19 (-26.10%)
At close: Nov 13, 2026, 4:00 PM EST
6.10
-0.10 (-1.61%)
After-hours: Nov 13, 2026, 7:55 PM EST
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $486.36 million as of November 13, 2026. It is the 14,533rd most valuable company in the world and the 2,724th biggest in the United States. Its market cap has increased by 80.08% in one year.
Market Cap
486.36M
Enterprise Value
333.02M
1-Year Change
80.08%
Global Rank
Country Rank
#2,724 United States
Category
ChartMarket Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $486.36M, an increase of 118.70%. That is a compound annual growth rate of 15.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 486.36M | 56.80% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immix Biopharma | 669.03M |
| Zevra Therapeutics | 664.07M |
| Ginkgo Bioworks Holdings | 663.08M |
| Cullinan Therapeutics | 661.54M |
| Olema Pharmaceuticals | 658.80M |
| Helus Pharma | 647.31M |
| Geron | 640.37M |
| Climb Bio | 638.48M |